These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23647893)

  • 21. Intracoronary continuous adenosine infusion.
    Koo BK; Kim CH; Na SH; Youn TJ; Chae IH; Choi DJ; Kim HS; Lee MM; Oh BH; Park YB; Choi YS; Tahk SJ
    Circ J; 2005 Aug; 69(8):908-12. PubMed ID: 16041158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.
    Nishi T; Kitahara H; Fujimoto Y; Nakayama T; Nagashima K; Hanaoka H; Kobayashi Y
    Heart Vessels; 2018 Dec; 33(12):1570-1575. PubMed ID: 29858919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve.
    Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y
    J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis.
    Ishibuchi K; Fujii K; Otsuji S; Takiuchi S; Hasegawa K; Tamaru H; Ishii R; Yasuda S; Nakabayashi S; Yamamoto W; Kusumoto H; Taniguchi Y; Kakishita M; Shimatani Y; Higashino Y
    Circ J; 2019 Sep; 83(10):2010-2016. PubMed ID: 31413232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of a hybrid approach of instantaneous wave-free ratio and fractional flow reserve using high-dose intracoronary adenosine to characterize intermediate coronary lesions: Results of the PALS (Practical Assessment of Lesion Severity) prospective study.
    Rivero F; Cuesta J; Bastante T; Benedicto A; García-Guimaraes M; Fuentes-Ferrer M; Alvarado T; Alfonso F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1070-1076. PubMed ID: 28544741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of regadenoson and nitroprusside to adenosine for measurement of fractional flow reserve: A systematic review and meta-analysis.
    Lee JZ; Singh N; Nyotowidjojo I; Howe C; Low SW; Nguyen T; Pinto D; Kumar G; Lee KS
    Cardiovasc Revasc Med; 2018 Mar; 19(2):168-174. PubMed ID: 28888873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of regadenoson for measurement of fractional flow reserve.
    Prasad A; Zareh M; Doherty R; Gopal A; Vora H; Somma K; Mehra A; Clavijo LC; Matthews RV; Shavelle DM
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):369-74. PubMed ID: 23765847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intracoronary versus intravenous administration of adenosine for measurement of coronary fractional flow reserve.
    Schlundt C; Bietau C; Klinghammer L; Wiedemann R; Rittger H; Ludwig J; Achenbach S
    Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25908694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of hyperemic efficacy between central and peripheral venous adenosine infusion for fractional flow reserve measurement.
    Seo MK; Koo BK; Kim JH; Shin DH; Yang HM; Park KW; Lee HY; Kang HJ; Kim HS; Oh BH; Park YB
    Circ Cardiovasc Interv; 2012 Jun; 5(3):401-5. PubMed ID: 22647519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment.
    Johnson NP; Jeremias A; Zimmermann FM; Adjedj J; Witt N; Hennigan B; Koo BK; Maehara A; Matsumura M; Barbato E; Esposito G; Trimarco B; Rioufol G; Park SJ; Yang HM; Baptista SB; Chrysant GS; Leone AM; Berry C; De Bruyne B; Gould KL; Kirkeeide RL; Oldroyd KG; Pijls NHJ; Fearon WF
    JACC Cardiovasc Interv; 2016 Apr; 9(8):757-767. PubMed ID: 27101902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of effectiveness of high-dose intracoronary adenosine versus intravenous administration on the assessment of fractional flow reserve in patients with coronary heart disease.
    López-Palop R; Carrillo P; Frutos A; Cordero A; Agudo P; Mashlab S; Bertomeu-Martínez V
    Am J Cardiol; 2013 May; 111(9):1277-83. PubMed ID: 23415635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous intracoronary versus standard intravenous infusion of adenosine for fractional flow reserve assessment: the HYPEREMIC trial.
    Elghamaz A; Myat A; de Belder A; Collison D; Cocks K; Stone GW; Oldroyd K
    EuroIntervention; 2020 Sep; 16(7):560-567. PubMed ID: 31289017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5'-triphosphate infusion.
    Takami H; Sonoda S; Muraoka Y; Sanuki Y; Kashiyama K; Fukuda S; Oginosawa Y; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2017 Jan; 69(1):119-124. PubMed ID: 26947100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the novel vasodilator uridine triphosphate and adenosine for the measurement of fractional flow reserve.
    Sivertsen J; Jensen J; Galatius S; Raunsø J; Rosenmeier J
    J Invasive Cardiol; 2014 Oct; 26(10):512-8. PubMed ID: 25274861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
    Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine-induced maximal coronary hyperemia for myocardial fractional flow reserve measurements: comparison of administration by femoral venous versus antecubital venous access.
    Lindstaedt M; Bojara W; Holland-Letz T; Yazar A; Fadgyas T; Müller L; Mügge A; Germing A
    Clin Res Cardiol; 2009 Nov; 98(11):717-23. PubMed ID: 19685258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements.
    Kato D; Takashima H; Waseda K; Kurita A; Kuroda Y; Kosaka T; Kuhara Y; Ando H; Maeda K; Kumagai S; Sakurai S; Suzuki A; Toda Y; Watanabe A; Sato S; Fujimoto M; Mizuno T; Amano T
    Heart Vessels; 2015 Jul; 30(4):477-83. PubMed ID: 24748047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Khashaba A; Mortada A; Omran A
    Clin Med Insights Cardiol; 2014; 8():17-21. PubMed ID: 24558302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.